Miach Orthopaedics announced study results showing that torn anterior cruciate ligaments (ACLs) treated with the Bridge-Enhanced® ACL Repair (BEAR®) implant were similar to the native ACL at one year.
Personalized Stem Cells received FDA approval for an Investigational New Drug application for use of a person's own stem cells to treat osteoarthritis.
Alphatec commenced commercial release of InVictus, a spinal fixation platform to treat a range of pathologies via MIS, open or hybrid surgical approaches.